ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 1,360 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $6 | 0.0% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6 | -25.0% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8 | -99.9% | 1,360 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | -60.0% | 1,360 | -56.1% | 0.00% | -50.0% |
| Q2 2022 | $35,000 | -63.2% | 3,100 | -72.4% | 0.00% | -60.0% |
| Q1 2022 | $95,000 | -5.0% | 11,242 | -18.2% | 0.01% | +25.0% |
| Q4 2021 | $100,000 | +132.6% | 13,742 | +708.4% | 0.00% | +100.0% |
| Q3 2021 | $43,000 | -12.2% | 1,700 | -32.0% | 0.00% | 0.0% |
| Q2 2021 | $49,000 | +250.0% | 2,500 | +525.0% | 0.00% | +100.0% |
| Q1 2021 | $14,000 | -26.3% | 400 | -91.8% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | -50.0% | 4,900 | +4.3% | 0.00% | -50.0% |
| Q2 2020 | $38,000 | – | 4,700 | +4600.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 100 | -98.3% | 0.00% | -100.0% |
| Q3 2019 | $30,000 | – | 5,900 | +1866.7% | 0.00% | – |
| Q2 2019 | $0 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |